What one share of Insulet holds
Insulet Corporation (“we” or the “Company”) is primarily engaged in the development, manufacture, and sale of its proprietary continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod platform includes: the Omnipod® 5 Automated Insulin Delivery System (“Omnipod 5”), the Omnipod DASH® Insulin Management System (“Omnipod DASH”), and the Omnipod Insulin Management System (“Classic Omnipod”).
Insulet’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $42.72 |
|---|---|
| Profit | $5.25 |
| Capex (buildings and equipment) | $3.04 |
| Free cash flow | $4.11 |
| Cash and investments | $7.71 |
| Debt | $13.68 |
| Book value | $20.51 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $2.22 | −$2.43 | $0.11 | −$1.76 | — | $2.08 |
| 2010 | $2.45 | −$1.54 | $0.17 | −$1.06 | — | $1.46 |
| 2011 | $3.26 | −$0.98 | $0.24 | −$0.78 | — | $1.74 |
| 2012 | $4.41 | −$1.08 | $0.23 | −$0.84 | — | $0.91 |
| 2013 | $4.57 | −$0.83 | $0.14 | −$0.07 | — | $2.27 |
| 2014 | $4.16 | −$0.93 | $0.21 | −$0.05 | — | $1.49 |
| 2015 | $4.65 | −$1.29 | $0.19 | −$0.41 | — | $0.60 |
| 2016 | $6.41 | −$0.48 | $0.39 | −$0.11 | — | $1.10 |
| 2017 | $8.00 | −$0.46 | $1.27 | −$0.56 | — | $2.72 |
| 2018 | $9.24 | $0.05 | $2.58 | −$1.99 | — | $3.58 |
| 2019 | $11.85 | $0.19 | $2.63 | −$1.05 | — | $1.21 |
| 2020 | $13.71 | $0.10 | $1.96 | −$0.68 | — | $9.14 |
| 2021 | $16.02 | $0.24 | $1.63 | −$2.62 | — | $8.04 |
| 2022 | $18.67 | $0.07 | $1.76 | −$0.06 | — | $6.85 |
| 2023 | $23.05 | $2.94 | $1.03 | $0.95 | — | $10.48 |
| 2024 | $28.04 | $5.78 | $1.69 | $4.13 | — | $17.26 |
| 2025 | $37.67 | $3.48 | $2.67 | $5.25 | — | $21.53 |
Common questions about Insulet
How much does one share of Insulet earn?
Over the last 12 months, each share of Insulet earned $5.25 of profit on $42.72 of sales, keeping about 12¢ of every $1 (profit margin).
Does Insulet pay a dividend?
Insulet didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Insulet’s book value per share?
Insulet’s book value is $20.51 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Insulet have?
Each share of Insulet has $7.71 of cash and investments and $13.68 of debt, as of June 30, 2026.
What is Insulet’s free cash flow per share?
$4.11 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Insulet bought back shares?
Insulet’s share count rose about 141% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.